Aptamers: Current challenges and future prospects

Expert Opinion on Drug Discovery

Volumn 11, Issue 2, 2016, Pages 127-135

  Rozenblum, Guido Tomás ^a   Lopez, Vanina Gisela ^a   Vitullo, Alfredo Daniel ^a   Radrizzani, Martín ^b  

^a DEPARTAMENTO DE CIENCIAS NATURALES Y ANTROPOLOGÍA   (Argentina)

^b UNIVERSIDAD NACIONAL DE SAN MARTÍN   (Argentina)

Author keywords

Aptamers; biosensors; combinatorial chemistry; DNA arrays; drug discovery; lead compounds; nanostructures; non SELEX; SELEX

Indexed keywords

APTAMER; NANOCARRIER; NANOMATERIAL; ANTIBODY;

IMMUNOGENICITY; IN VITRO SELECTION; NANOSENSOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SOLUTION AND SOLUBILITY; ANIMAL; COMBINATORIAL CHEMISTRY; COMPARATIVE STUDY; GENE LIBRARY; HUMAN; METABOLISM; PROCEDURES; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT APTAMER TECHNIQUE;

ANIMALS; ANTIBODIES; APTAMERS, NUCLEOTIDE; COMBINATORIAL CHEMISTRY TECHNIQUES; GENE LIBRARY; HUMANS; SELEX APTAMER TECHNIQUE;

EID: 84957428650     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.2016.1126244     Document Type: Review

References (78)

1. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990; 249 (4968): 505-510.
2. Gordon EM, Barrett RW, Dower WJ, et al. Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions. J Med Chem 1994 May 13; 37 (10): 1385-1401
3. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 1985; 228 (4705): 1315-1317.
4. He M, Taussig MJ. Eukaryotic ribosome display with in situ DNA recovery. Nat Methods. 2007 Mar; 4 (3): 281-288.
5. Stoltenburg R, Reinemann C, Strehlitz B. SELEX-a (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng. 2007; 24 (4): 381-403.
6. Seok Kim Y, Ahmad Raston NH, Bock Gu M. Aptamer-based nanobiosensors. Biosens Bioelectron. 2015. DOI: http://dx.doi.org/10.1016/j.bios.2015.06.040i
7. Gragoudas ES, Adamis AP, Cunningham ET Jr., et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004 Dec 30; 351 (27): 2805-2816
8. Ni X, Castanares M, Mukherjee A, et al. Nucleic acid aptamers: clinical applications and promising new horizons. Curr Med Chem. 2011; 18 (27): 4206-4214.
9. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975; 256 (5517): 495-497.
10. Blow N. Antibodies: the generation game. Nature. 2007; 447 (7145): 741-744.
11. Bordeaux J, Welsh A, Agarwal S, et al. Antibody validation. BioTechniques. 2010; 48 (3): 197-209.
12. Baird GS. Where are all the aptamers? Am J Clin Pathol. 2010 Oct; 134 (4): 529-531.
13. Burke PA. The ups and downs of clinical translation of new technologies: deja vu all over again. Mol Ther. 2015 May; 23 (5): 791-792.
14. Bruno JG. Predicting the uncertain future of aptamer-based diagnostics and therapeutics. Molecules. 2015; 20 (4): 6866-6887.
15. Musheev MU, Krylov SN. Selection of aptamers by systematic evolution of ligands by exponential enrichment: addressing the polymerase chain reaction issue. Analytica Chimica Acta. 2006 Mar 30; 564 (1): 91-96.
16. Tolle F, Wilke J, Wengel J, et al. By-product formation in repetitive PCR amplification of DNA libraries during SELEX. PLoS ONE. 2014; 9 (12): e114693.
17. Schutze T, Wilhelm B, Greiner N, et al. Probing the SELEX process with next-generation sequencing. PLoS ONE. 2011; 6 (12): e29604.
18. Nimjee SM, Rusconi CP, Sullenger BA. Aptamers: an emerging class of therapeutics. Annu Rev Med. 2005; 56: 555-583.
19. Jayasena SD. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem. 1999 Sep; 45 (9): 1628-1650.
20. Hall B, Micheletti JM, Satya P, et al. Design, synthesis, and amplification of DNA pools for in vitro selection. Current Protocols in Molecular Biology. John Wiley & Sons, Inc; 2001.
21. Glokler J, Schutze T, Konthur Z. Automation in the high-throughput selection of random combinatorial libraries-different approaches for select applications. Molecules. 2010 Apr; 15 (4): 2478-2490.
22. Rusconi CP, Yeh A, Lyerly HK, et al. Blocking the initiation of coagulation by RNA aptamers to factor VIIa. Thromb Haemost. 2000; 84 (5): 841-848.
23. Eyetech Study G. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration. Retina. 2002 Apr; 22 (2): 143-152.
24. Oney S, Lam RT, Bompiani KM, et al. Development of universal antidotes to control aptamer activity. Nat Med. 2009 Oct; 15 (10): 1224-1228.
25. Rusconi CP, Scardino E, Layzer J, et al. RNA aptamers as reversible antagonists of coagulation factor IXa. Nature 2002 Sep 5; 419 (6902): 90-94
26. Ramaswamy G, Slack FJ. siRNA. A guide for RNA silencing. Chem Biol. 2002 Oct; 9 (10): 1053-1055.
27. McNamara JO 2nd, Andrechek ER, Wang Y, et al. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol. 2006; 24 (8): 1005-1015.
28. Dassie JP, Liu XY, Thomas GS, et al. Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors. Nat Biotechnol. 2009; 27 (9): 839-849.
29. Thiel KW, Hernandez LI, Dassie JP, et al. Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers. Nucl Acid Res. 2012 Jul;40(13):6319-6337.
30. Gourronc FA, Rockey WM, Thiel WH, et al. Identification of RNA aptamers that internalize into HPV-16 E6/E7 transformed tonsillar epithelial cells. Virology. 2013; 446 (1-2): 325-333.
31. Zhou J, Bobbin ML, Burnett JC, et al. Current progress of RNA aptamer-based therapeutics. Front Genet. 2012; 3: 234.
32. Zhou J, Li H, Li S, et al. Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy. Mol Ther. 2008; 16 (8): 1481-1489.
33. Seeman NC. DNA in a material world. Nature. 2003; 421 (6921): 427-431.
34. Goodman RP, Berry RM, Turberfield AJ. The single-step synthesis of a DNA tetrahedron. Chem Commun. 2004 Jun; 21 (12): 1372-1373.
35. Liu Y, Lin C, Li H, et al. Aptamer-directed self-assembly of protein arrays on a DNA nanostructure. Angewandte Chemie (International Ed 2005 Jul 11; 44 (28): 4333-4338
36. Shu Y, Cinier M, Shu D, et al. Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells. Methods. 2011; 54 (2): 204-214.
37. Zhou J, Shu Y, Guo P, et al. Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition. Methods. 2011; 54 (2): 284-294.
38. Khaled A, Guo S, Li F, et al. Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology. Nano Letters. 2005; 5 (9): 1797-1808.
39. Niemeyer CM, Adler M. Nanomechanical devices based on DNA. Angewandte Chemie (International Ed). 2002; 41 (20): 3779-3783.
40. Dittmer WU, Reuter A, Simmel FC. A DNA-based machine that can cyclically bind and release thrombin. Angewandte Chemie (International Ed). 2004; 43 (27): 3550-3553.
41. Douglas SM, Bachelet I, Church GM. A logic-gated nanorobot for targeted transport of molecular payloads. Science. 2012; 335 (6070): 831-834.
42. Liao WC, Lu CH, Hartmann R, et al. Adenosine triphosphate-triggered release of macromolecular and nanoparticle loads from aptamer/DNA-cross-linked microcapsules. ACS Nano; 2015 Sep 22;9(9):9078-9086.
43. Kanagawa T. Bias and artifacts in multitemplate polymerase chain reactions (PCR). J Biosci Bioeng. 2003; 96 (4): 317-323.
44. Dutton CM, Paynton C, Sommer SS. General method for amplifying regions of very high G+C content. Nucleic Acids Res. 1993; 21 (12): 2953-2954.
45. Margulies M, Egholm M, Altman WE, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005 Sep 15; 437 (7057): 376-380
46. Fedurco M, Romieu A, Williams S, et al. BTA, a novel reagent for DNA attachment on glass and efficient generation of solid-phase amplified DNA colonies. Nucleic Acids Res. 2006; 34 (3): e22.
47. Hoinka J, Berezhnoy A, Sauna ZE, et al. AptaCluster-a method to cluster HT-SELEX aptamer pools and lessons from its application. Res Comput Mol Biol. 2014; 8394: 115-128.
48. Hoinka J, Berezhnoy A, Dao P, et al. Large scale analysis of the mutational landscape in HT-SELEX improves aptamer discovery. Nucleic Acids Res 2015 Jul 13; 43 (12): 5699-5707
49. Shao K, Ding W, Wang F, et al. Emulsion PCR: a high efficient way of PCR amplification of random DNA libraries in aptamer selection. PLoS ONE. 2011; 6 (9): e24910.
50. Szeitner Z, Andras J, Gyurcsanyi RE, et al. Is less more? Lessons from aptamer selection strategies. J Pharm Biomed Anal. 2014 Dec; 101: 58-65.
51. Gopinath SC. Methods developed for SELEX. Anal Bioanal Chem. 2007 Jan; 387 (1): 171-182.
52. Cox JC, Ellington AD. Automated selection of anti-protein aptamers. Bioorg Med Chem. 2001 Oct; 9 (10): 2525-2531.
53. Mendonsa SD, Bowser MT. In vitro evolution of functional DNA using capillary electrophoresis. J Am Chem Soc. 2004; 126 (1): 20-21.
54. Berezovski M, Drabovich A, Krylova SM, et al. Nonequilibrium capillary electrophoresis of equilibrium mixtures: a universal tool for development of aptamers. J Am Chem Soc 2005 Mar 9; 127 (9): 3165-3171
55. Lou X, Qian J, Xiao Y, et al. Micromagnetic selection of aptamers in microfluidic channels. Proc Natl Acad Sci USA. 2009; 106 (9): 2989-2994.
56. Cho M, Xiao Y, Nie J, et al. Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing. Proc Natl Acad Sci USA 2010 Aug 31; 107 (35): 15373-15378
57. Qian J, Lou X, Zhang Y, et al. Generation of highly specific aptamers via micromagnetic selection. Anal Chem 2009 Jul 1; 81 (13): 5490-5495
58. Oh SS, Ahmad KM, Cho M, et al. Improving aptamer selection efficiency through volume dilution, magnetic concentration, and continuous washing in microfluidic channels. Anal Chem 2011 Sep 1; 83 (17): 6883-6889
59. Park JW, Tatavarty R, Kim DW, et al. Immobilization-free screening of aptamers assisted by graphene oxide. Chem Commun 2012 Feb 18; 48 (15): 2071-2073
60. Riley KR, Saito S, Gagliano J, et al. Facilitating aptamer selection and collection by capillary transient isotachophoresis with laser-induced fluorescence detection. J Chromatogr. 2014 Nov 14; 1368: 183-189
61. Jing M, Bowser MT. Isolation of DNA aptamers using micro free flow electrophoresis. Lab on a Chip. 2011; 11 (21): 3703-3709.
62. Gold L, Ayers D, Bertino J, et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE. 2010; 5 (12): e15004.
63. Fujita S, Arinaga K, Fujihara T, et al. Novel protein detection system using DNA as constituent material. Fujitsu Sci Tech J. 2012 April;48(2):237-243.
64. Williams KP, Liu XH, Schumacher TN, et al. Bioactive and nuclease-resistant L-DNA ligand of vasopressin. Proc Natl Acad Sci USA 1997 Oct 14; 94 (21): 11285-11290
65. Klussmann S, Nolte A, Bald R, et al. Mirror-image RNA that binds D-adenosine. Nat Biotechnol. 1996; 14 (9): 1112-1115.
66. Green LS, Jellinek D, Bell C, et al. Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor. Chem Biol. 1995; 2 (10): 683-695.
67. Diafa S, Hollenstein M. Generation of aptamers with an expanded chemical repertoire. Molecules. 2015; 20 (9): 16643-16671.
68. Eaton BE. The joys of in vitro selection: chemically dressing oligonucleotides to satiate protein targets. Curr Opin Chem Biol. 1997 Jun; 1 (1): 10-16.
69. Loakes D, Holliger P. Polymerase engineering: towards the encoded synthesis of unnatural biopolymers. Chem Commun. 2009 Aug; 21 (31): 4619-4631.
70. Pinheiro VB, Taylor AI, Cozens C, et al. Synthetic genetic polymers capable of heredity and evolution. Science 2012 Apr 20; 336 (6079): 341-344
71. Chushak Y, Stone MO. In silico selection of RNA aptamers. Nucleic Acids Res. 2009 Jul; 37 (12): e87.
72. Asai R, Nishimura SI, Takahashi K. DNA aptamers that recognize fluorophore using on-chip screening in combination with an in silico evolution. Nucleic Acids Res. 2003; 3: 321-322.
73. Maurer K, Yazvenko N, Wilmoth J, et al. Use of a multiplexed CMOS microarray to optimize and compare oligonucleotide binding to DNA probes synthesized or immobilized on individual electrodes. Sensors. 2010; 10 (8): 7371-7385.
74. Cho M, Soo Oh S, Nie J, et al. Quantitative selection and parallel characterization of aptamers. Proc Natl Acad Sci USA 2013 Nov 12; 110 (46): 18460-18465
75. Cagnin S, Caraballo M, Guiducci C, et al. Overview of electrochemical DNA biosensors: new approaches to detect the expression of life. Sensors. 2009; 9 (4): 3122-3148.
76. Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol. 2008 Oct; 26 (10): 1135-1145.
77. Holt RA, Jones SJ. The new paradigm of flow cell sequencing. Genome Res. 2008; 18 (6): 839-846.
78. Merriman B, Ion Torrent R, Team D, et al. Progress in ion torrent semiconductor chip based sequencing. Electrophoresis. 2012; 33 (23): 3397-3417.